Intellipharmaceutics International Inc. (IPCIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 29, 2025
IPCIQ Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 33.09M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -107.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 20.04% |
| Revenue Per Employee | 82,268 |
| Profits Per Employee | -288,528 |
| Employee Count | 11 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IPCIQ has paid 5,337 in taxes.
| Income Tax | 5,337 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 42.33 |
| Average Volume (20 Days) | 78,930 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IPCIQ had revenue of 904,946 and -3.17 million in losses. Loss per share was -0.09.
| Revenue | 904,946 |
| Gross Profit | 429,059 |
| Operating Income | -2.58M |
| Pretax Income | -3.17M |
| Net Income | -3.17M |
| EBITDA | -2.41M |
| EBIT | -2.58M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 400,102 in cash and 2.22 million in debt, giving a net cash position of -1.82 million.
| Cash & Cash Equivalents | 400,102 |
| Total Debt | 2.22M |
| Net Cash | -1.82M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -12.88M |
| Book Value Per Share | -0.39 |
| Working Capital | -13.58M |
Cash Flow
| Operating Cash Flow | 120,453 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 47.41% |
| Operating Margin | -285.07% |
| Pretax Margin | -350.13% |
| Profit Margin | n/a |
| EBITDA Margin | -266.03% |
| EBIT Margin | -285.07% |
| FCF Margin | n/a |
Dividends & Yields
IPCIQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.88% |
| Shareholder Yield | -24.88% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 14, 2018. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
IPCIQ has an Altman Z-Score of -111.24 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -111.24 |
| Piotroski F-Score | 5 |